DK1952142T3 - Opløsningssammensætning til undersøgelse af lægemiddelopløselighed - Google Patents
Opløsningssammensætning til undersøgelse af lægemiddelopløselighedInfo
- Publication number
- DK1952142T3 DK1952142T3 DK06818475.3T DK06818475T DK1952142T3 DK 1952142 T3 DK1952142 T3 DK 1952142T3 DK 06818475 T DK06818475 T DK 06818475T DK 1952142 T3 DK1952142 T3 DK 1952142T3
- Authority
- DK
- Denmark
- Prior art keywords
- drug solubility
- study
- solution composition
- intestinal
- composition
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0522942.2A GB0522942D0 (en) | 2005-11-10 | 2005-11-10 | Dissolution composition |
| PCT/EP2006/010809 WO2007054342A1 (en) | 2005-11-10 | 2006-11-10 | Dissolution composition for examining drug solubility |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1952142T3 true DK1952142T3 (da) | 2012-07-09 |
Family
ID=35516698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06818475.3T DK1952142T3 (da) | 2005-11-10 | 2006-11-10 | Opløsningssammensætning til undersøgelse af lægemiddelopløselighed |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US8287907B2 (da) |
| EP (1) | EP1952142B1 (da) |
| AT (1) | ATE550647T1 (da) |
| AU (1) | AU2006311169B2 (da) |
| CA (1) | CA2627945C (da) |
| DK (1) | DK1952142T3 (da) |
| ES (1) | ES2385517T3 (da) |
| GB (1) | GB0522942D0 (da) |
| NO (1) | NO339702B1 (da) |
| NZ (1) | NZ567873A (da) |
| PL (1) | PL1952142T3 (da) |
| PT (1) | PT1952142E (da) |
| SI (1) | SI1952142T1 (da) |
| WO (1) | WO2007054342A1 (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8658202B2 (en) | 2001-04-25 | 2014-02-25 | Western University Of Health Sciences | Coated drug delivery formulations |
| WO2008040799A2 (en) * | 2006-10-06 | 2008-04-10 | Boehringer Ingelheim International Gmbh | Process for preparing instant forms of aqueous mixed micellar solutions as physiological buffer systems for use in the analysis of in vitro release |
| JP2011506934A (ja) * | 2007-12-06 | 2011-03-03 | ペイン セラピューティクス インコーポレイテッド | 溶解試験装置および試験のための方法 |
| EP2645099A1 (en) * | 2012-03-30 | 2013-10-02 | Phares Pharmaceutical Research N.V. | Biorelevant compositions |
| GB2566688B (en) | 2017-09-16 | 2020-03-25 | Univ Of Hertfordshire Higher Education Corporation | Apparatus, buffer and method for pH control |
| USD907235S1 (en) | 2017-09-18 | 2021-01-05 | University Of Hertfordshire Higher Education Corporation | Enclosure for dissolution system |
| GB201809627D0 (en) * | 2018-06-12 | 2018-07-25 | Biorelevant Com Ltd | Methods for preparing buffer solutions suitable for in vitro drug dissolution testing, drug solubility testing and/or drug profiling |
| GB201904757D0 (en) * | 2019-04-04 | 2019-05-22 | Biorelevant Com Ltd | Biorelevant composition |
| MA56384A (fr) * | 2019-06-28 | 2022-05-04 | Janssen Pharmaceutica Nv | Milieux de dissolution biologiquement pertinents |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53107408A (en) * | 1977-02-28 | 1978-09-19 | Yamanouchi Pharmaceut Co Ltd | Micellar preparation for rectal infusion |
| US5674855A (en) | 1992-08-12 | 1997-10-07 | The Rogosin Institute | Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions |
| US5830853A (en) * | 1994-06-23 | 1998-11-03 | Astra Aktiebolag | Systemic administration of a therapeutic preparation |
| JP2740153B2 (ja) * | 1995-03-07 | 1998-04-15 | エフ・ホフマン−ラ ロシユ アーゲー | 混合ミセル |
| US5759445A (en) * | 1995-05-24 | 1998-06-02 | Matsushita Electric Industrial Co., Ltd. | Lipid-dispersed solution and process for producing the same |
| CA2282411A1 (en) * | 1997-02-27 | 1998-09-03 | Nippon Shinyaku Co., Ltd. | Fat emulsion for oral administration |
| SE0001453D0 (sv) * | 2000-04-19 | 2000-04-19 | Astrazeneca Ab | Method of monitoring a freeze drying process |
| CN1298702A (zh) * | 2000-10-23 | 2001-06-13 | 云南汉德生物技术有限公司 | 红豆素ⅵ水溶性粉针剂及其制备方法和用途 |
| US8658202B2 (en) * | 2001-04-25 | 2014-02-25 | Western University Of Health Sciences | Coated drug delivery formulations |
-
2005
- 2005-11-10 GB GBGB0522942.2A patent/GB0522942D0/en not_active Ceased
-
2006
- 2006-11-10 AT AT06818475T patent/ATE550647T1/de active
- 2006-11-10 DK DK06818475.3T patent/DK1952142T3/da active
- 2006-11-10 US US12/084,806 patent/US8287907B2/en active Active
- 2006-11-10 AU AU2006311169A patent/AU2006311169B2/en active Active
- 2006-11-10 PT PT06818475T patent/PT1952142E/pt unknown
- 2006-11-10 WO PCT/EP2006/010809 patent/WO2007054342A1/en active Application Filing
- 2006-11-10 EP EP06818475A patent/EP1952142B1/en active Active
- 2006-11-10 PL PL06818475T patent/PL1952142T3/pl unknown
- 2006-11-10 SI SI200631354T patent/SI1952142T1/sl unknown
- 2006-11-10 ES ES06818475T patent/ES2385517T3/es active Active
- 2006-11-10 CA CA2627945A patent/CA2627945C/en active Active
- 2006-11-10 NZ NZ567873A patent/NZ567873A/en unknown
-
2008
- 2008-05-02 NO NO20082078A patent/NO339702B1/no unknown
-
2012
- 2012-10-16 US US13/652,837 patent/US8889189B2/en active Active
-
2014
- 2014-11-18 US US14/546,981 patent/US20160299113A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20160299113A1 (en) | 2016-10-13 |
| SI1952142T1 (sl) | 2012-08-31 |
| ES2385517T3 (es) | 2012-07-26 |
| AU2006311169A1 (en) | 2007-05-18 |
| US20130055831A1 (en) | 2013-03-07 |
| US8889189B2 (en) | 2014-11-18 |
| CA2627945C (en) | 2016-09-06 |
| NZ567873A (en) | 2011-11-25 |
| CA2627945A1 (en) | 2007-05-18 |
| WO2007054342A1 (en) | 2007-05-18 |
| NO20082078L (no) | 2008-07-11 |
| GB0522942D0 (en) | 2005-12-21 |
| US20090145248A1 (en) | 2009-06-11 |
| ATE550647T1 (de) | 2012-04-15 |
| EP1952142A1 (en) | 2008-08-06 |
| EP1952142B1 (en) | 2012-03-21 |
| NO339702B1 (no) | 2017-01-23 |
| PT1952142E (pt) | 2012-06-26 |
| AU2006311169B2 (en) | 2013-05-09 |
| US8287907B2 (en) | 2012-10-16 |
| PL1952142T3 (pl) | 2012-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1952142T3 (da) | Opløsningssammensætning til undersøgelse af lægemiddelopløselighed | |
| EA200870217A1 (ru) | 4-арил-2-аминопиримидины или 4-арил-2-аминоалкилпиримидины в качестве модуляторов jak-2 и содержащие их фармацевтические композиции | |
| CY1109010T1 (el) | γ-ΚΡΥΣΤΑΛΛΙΚΗ ΜΟΡΦΗ ΤΗΣ ΥΔΡΟΧΛΩΡΙΚΗΣ ΙΒΑΒΡΑΔΙΝΗΣ, ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΤΗΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΕΧΟΥΝ | |
| CY1109916T1 (el) | Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις | |
| NO20092611L (no) | Krystallinsk faststoff Rasagilin base | |
| GT200600520A (es) | Agentes antibacterianos | |
| CY1113199T1 (el) | Σταθεροποιημενες συνθεσεις γλυκοσερεμπροσιδασης | |
| AR051397A1 (es) | Composicion farmaceutica | |
| IL198687A0 (en) | Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses | |
| DK2266422T3 (da) | Synergi af GOS og polyfructose | |
| AR066042A1 (es) | Moleculas y metodos para modular la proteina convertasa-subtilisina /quexina tipo 9 (pcsk9) | |
| CL2008003284A1 (es) | Compuestos derivados de 4-bencilamino-1-carboxiacil-piridina, inhibidores cetp; composicion farmaceutica que los comprende; combinacion farmaceutica; y uso en el tratamiento de enfermedades metabolicas, ateroesclerosis y cardiovasculares, entre otras. | |
| GT200800107A (es) | Formulaciones orales que comprenden tigeciclina | |
| CL2008001017A1 (es) | Compuestos derivados de indol, activadores de glucoquinasa; composicion farmaceutica que los comprende; y su uso para la prevencion o el tratamiento de diabetes u obesidad. | |
| DK3308788T3 (da) | Sammensætninger og fremgangsmåder til modulering af smn2-splejsning | |
| CY1110221T1 (el) | Σταθερα φαρμακευτικα σκευασματα νατριουχου μοντελουκαστης | |
| AR047928A1 (es) | Derivados de tetrahidropiridoindol | |
| UY30304A1 (es) | Moduladores de mglur5 i | |
| CU20060038A7 (es) | Forma cristalina gamma-d del clorhidrato de la ivabradina, su procedimiento de preparación y las composiciones farmacéuticas que las contienen | |
| UY30308A1 (es) | Moduladores de mglur5 v | |
| CY1120206T1 (el) | Μεθοδοι για τη συγκλινουσα συνθεση παραγωγων καλιχεαμικινης | |
| UY30307A1 (es) | Moduladores de mglur5 vi | |
| UY30306A1 (es) | Moduladores de mglur5 iii | |
| CY1112960T1 (el) | Παραγωγα ουριας, μεθοδοι για την παρασκευη τους και χρησεις αυτων | |
| DK2038294T3 (da) | 18-methyl-19-nor-androst-4-en-17,17-spiroether (18-methyl-19-nor-20-spirox-4-en-3-oner) og farmaceutiske præparater, der indeholder disse |